LOS ANGELES CAPITAL MANAGEMENT LLC
Position in RPRX — Royalty Pharma plc
CIK 1177206
LOS ANGELES, CA
Position in RPRX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$46,623,338
-$866,613 QoQ
Shares Held
971,927
-20.9% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $690,033,476 across 153 Biotechnology names. RPRX ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
2,144,847 | $201,872,999 | |
| 2 | EXEL |
Exelixis, Inc.
|
3,102,634 | $133,071,972 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,880 | $60,945,843 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
971,927 | $46,623,338 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
689,915 | $44,589,206 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
2,289,602 | $40,938,083 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
88,278 | $29,208,541 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
64,937 | $28,996,967 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,623,338 | 971,927 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $47,489,951 | 1,229,036 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $35,870,657 | 1,016,742 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $11,412,538 | 316,751 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $33,655,514 | 1,081,128 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,043,205 | 40,894 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $10,967,948 | 387,697 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $11,749,100 | 445,548 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $21,378,020 | 703,919 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $11,403,725 | 405,971 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $11,712,158 | 431,546 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $9,386,950 | 305,366 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $19,698,826 | 546,734 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $10,524,136 | 266,299 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $6,757,191 | 168,173 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $10,647,302 | 253,266 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $11,469,785 | 294,399 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $7,265,890 | 182,331 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $12,322,981 | 340,979 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $39,760,545 | 970,006 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $38,810,938 | 889,751 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $13,070,307 | 261,145 | Shares | Sole | 2021-03-10 | |
| No filing history on record for this holder in this stock. | ||||||